In this episode, our editor-in-chief Taissa Vila talks to Dr. Ernesto Bascolo (PAHO), Dr. Marcia Castro (Harvard T.H. Chan School of Public Health), and Dr. Cristian Herrera (World Bank) about their Commission report on primary health care resilience in Latin America and the Caribbean.

They discuss the goals, achievements, and next steps of the Commission, the regional context and the roles of the different stakeholders in building resilient healthcare systems that are equitable and accessible for all.

Click here to read the full Lancet Rregional Health Americas commission

We discuss the impact of methadone shortage on people who use opioids in Tijuana, Mexico, following the publication of a qualitative study on this topic in our September issue. Our senior editor Orison Woolcott spoke with Annick Bórquez, associate professor at University of California San Diego, California, USA, and Alicia Harvey-Vera, researcher at the same institution.

Read the full article:

https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(25)00186-3/fulltext?dgcid=buzzsprout_icw_podcast_September_25_laname

In this episode, our editor Taissa Vila talks to Dr. Scott Greer (University of Michigan) and Dr. Miranda Yaver (University of Pittsburgh) about the sweeping structural changes to US health policy during the first hundred days of Donald Trump’s second presidential term.

The conversation covers the administration’s executive actions and what these shifts mean for the sustainability of the US health system and the health of its people. Join us for expert insights on health impacts, public health risks, and the future of healthcare access and equity in the US.

Read the full article:

https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(25)00183-8/fulltext?dgcid=buzzsprout_icw_podcast_August_25_lanam

In this episode, our editor-in-chief Taissa Vila sits down with Dr. Beatriz Grinsztejn to discuss the challenges of expanding access to pre-exposure prophylaxis (PrEP), with a focus on issues of adherence and equity in Latin America.

We explore the potential of Lenacapavir as a game-changing intervention, reflect on lessons learned from previous experiences with injectable PrEP, and examine the critical importance of introducing new prevention tools through an equity-based approach.

Finally, we look ahead to what Lenacapavir could mean for the future of HIV prevention strategies worldwide. Tune in for an insightful conversation on how innovative strategies like Lenacapavir could reshape the future of HIV awareness and prevention.

Read the full article:

https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(25)00156-5/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laname

In this episode, join our editorial team for a lively roundtable as we introduce our new The Lancet Regional Health - Americas podcast channel and reflect on the first half of 2025. We share our favourite published articles of the year, discuss our vision for advancing clinical practice, health policy, and research across the Americas, and explore key health trends to watch in the coming months.